相似文献
1
Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission.
J Clin Microbiol. 1993 Nov;31(11):3017-22. doi: 10.1128/jcm.31.11.3017-3022.1993.
2
Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis.
Lancet. 1993 Jul 3;342(8862):15-9. doi: 10.1016/0140-6736(93)91881-l.
3
Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis.
N Engl J Med. 1994 Oct 13;331(15):981-7. doi: 10.1056/NEJM199410133311504.
4
Possible nosocomial transmission of Pseudomonas cepacia in patients with cystic fibrosis.
Arch Pediatr Adolesc Med. 1994 Aug;148(8):805-12. doi: 10.1001/archpedi.1994.02170080035006.
5
Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia.
Thorax. 1998 May;53(5):432-6. doi: 10.1136/thx.53.5.432.
6
Application of pyrolysis mass spectroscopy and SDS-PAGE in the study of the epidemiology of Pseudomonas cepacia in cystic fibrosis.
J Med Microbiol. 1994 Aug;41(2):106-11. doi: 10.1099/00222615-41-2-106.
7
Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis. Summer Camp Study Group.
J Pediatr. 1994 May;124(5 Pt 1):694-702. doi: 10.1016/s0022-3476(05)81357-5.
8
Pseudomonas cepacia pulmonary infection in adults with cystic fibrosis: is nosocomial acquisition occurring?
J Hosp Infect. 1992 Jul;21(3):199-204. doi: 10.1016/0195-6701(92)90076-x.
9
Epidemiology of Pseudomonas cepacia colonization among patients with cystic fibrosis.
Pediatr Pulmonol. 1994 Aug;18(2):108-13. doi: 10.1002/ppul.1950180210.
10
Transmission of Pseudomonas cepacia by social contact in cystic fibrosis.
Lancet. 1993 Aug 14;342(8868):434-5.
引用本文的文献
1
Therapeutic beta-lactam dosages and broad-spectrum antibiotics are associated with reductions in microbial richness and diversity in persons with cystic fibrosis.
Sci Rep. 2023 Jan 21;13(1):1217. doi: 10.1038/s41598-023-27628-x.
2
Infections in cystic fibrosis.
Semin Pediatr Infect Dis. 1995 Jul;6(3):174-181. doi: 10.1016/S1045-1870(05)80045-7. Epub 2006 May 31.
3
Epidemiology of in Cystic Fibrosis Airways Demonstrates the Capacity for Persistent Infection but Not Patient-Patient Transmission.
Front Microbiol. 2020 Mar 20;11:475. doi: 10.3389/fmicb.2020.00475. eCollection 2020.
4
Risk of Bacterial Transmission in Bronchiectasis Outpatient Clinics.
Curr Pulmonol Rep. 2018;7(3):72-78. doi: 10.1007/s13665-018-0203-6. Epub 2018 Jul 2.
5
A putative lateral flagella of the cystic fibrosis pathogen Burkholderia dolosa regulates swimming motility and host cytokine production.
PLoS One. 2018 Jan 18;13(1):e0189810. doi: 10.1371/journal.pone.0189810. eCollection 2018.
6
Diagnostics method for the rapid quantitative detection and identification of low-level contamination of high-purity water with pathogenic bacteria.
J Ind Microbiol Biotechnol. 2013 Sep;40(9):1005-13. doi: 10.1007/s10295-013-1295-1. Epub 2013 Jun 20.
7
Intercontinental spread of a highly transmissible clone of Pseudomonas cepacia proved by multilocus enzyme electrophoresis and ribotyping.
Can J Infect Dis. 1994 Mar;5(2):86-8. doi: 10.1155/1994/562641.
8
Burkholderia cenocepacia creates an intramacrophage replication niche in zebrafish embryos, followed by bacterial dissemination and establishment of systemic infection.
Infect Immun. 2010 Apr;78(4):1495-508. doi: 10.1128/IAI.00743-09. Epub 2010 Jan 19.
9
Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry in comparison to 16S rRNA gene sequencing for species identification of nonfermenting bacteria.
J Clin Microbiol. 2008 Jun;46(6):1946-54. doi: 10.1128/JCM.00157-08. Epub 2008 Apr 9.
10
A novel sensor kinase-response regulator hybrid controls biofilm formation and type VI secretion system activity in Burkholderia cenocepacia.
Infect Immun. 2008 May;76(5):1979-91. doi: 10.1128/IAI.01338-07. Epub 2008 Mar 3.
本文引用的文献
1
Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.
J Pediatr. 1984 Feb;104(2):206-10. doi: 10.1016/s0022-3476(84)80993-2.
2
Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome.
J Pediatr. 1985 Sep;107(3):382-7. doi: 10.1016/s0022-3476(85)80511-4.
3
Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis.
J Clin Microbiol. 1985 Jul;22(1):5-8. doi: 10.1128/jcm.22.1.5-8.1985.
4
Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist.
Am Rev Respir Dis. 1985 May;131(5):791-6. doi: 10.1164/arrd.1985.131.5.791.
5
Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes.
Chest. 1987 Apr;91(4):527-32. doi: 10.1378/chest.91.4.527.
6
Pseudomonas cepacia: decrease in colonization in patients with cystic fibrosis.
Am Rev Respir Dis. 1986 Oct;134(4):669-71. doi: 10.1164/arrd.1986.134.4.669.
7
Pseudomonas cepacia--fatal pulmonary infection in a patient with cystic fibrosis.
J Infect. 1986 Sep;13(2):157-8. doi: 10.1016/s0163-4453(86)92953-1.
8
Pseudomonas cepacia in the hospital setting: lack of transmission between cystic fibrosis patients.
J Pediatr. 1986 Jul;109(1):51-4. doi: 10.1016/s0022-3476(86)80571-6.
9
Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology.
J Pediatr. 1986 May;108(5 Pt 2):806-12. doi: 10.1016/s0022-3476(86)80749-1.
10
Pseudomonas cepacia in cystic fibrosis patients.
Am Rev Respir Dis. 1986 Oct;134(4):644-5. doi: 10.1164/arrd.1986.134.4.644.
Zotero 插件